GMT Capital’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-55,300	Closed	-$1.1M	–	104
2018 Q2	$1.1M	Buy	+55,300	New	+$1.1M	0.03%	99